Purdue's 'New' Oxycodone Pills Are Copycats, Acura Says
Purdue Pharma LP is improperly seeking approval for an abuse-resistant oxycodone formulation as a new drug instead of a copycat product, specialty drugmaker Acura Pharmaceuticals Inc. told the U.S. Food and...To view the full article, register now.
Already a subscriber? Click here to view full article